Login to Your Account

Medco's infectious disease business sells to Melinta for $270M

By Michael Fitzhugh
Staff Writer

Wednesday, November 29, 2017

True to a pledge to sell its infectious disease business before year-end in service of its cardiovascular care ambitions, The Medicines Co. has struck a deal with Melinta Therapeutics Inc., a growing infectious disease player. 

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription